TCS-OX2-29
CAS: 372523-75-6
Rif. 3D-XPA52375
| 5mg | Prezzo su richiesta | ||
| 10mg | Prezzo su richiesta | ||
| 25mg | Prezzo su richiesta | ||
| 50mg | Prezzo su richiesta | ||
| 100mg | Prezzo su richiesta |
Informazioni sul prodotto
- 1-Butanone, 1-(3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)-3,3-dimethyl-2-[(4-pyridinylmethyl)amino]-, (2S)-
- (2S)-2-(4-Pyridylmethylamino)-1-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-2-yl)-3,3-dimethylbutan-1-one
- (2S)-1-(3,4-Dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)-3,3-dimethyl-2-[(4-pyridinylmethyl)amino]-1-butanone
- Isoquinoline, 2-[(2S)-3,3-dimethyl-1-oxo-2-[(4-pyridinylmethyl)amino]butyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-
- TCS-OX 2-29
TCS-OX2-29 is a novel nicotinic acetylcholine receptor (nAChR) ligand that binds to the ventral and rostral ventrolateral tegmental areas of the brain. It has been shown to have an excitatory effect in animal models and was found to increase locomotor activity in rats. TCS-OX2-29 has been evaluated for its potential interaction with other compounds, including nicotine, which is used as a model for nAChR agonists. TCS-OX2-29 has been shown to be effective at doses of 20 mg/kg or higher when administered chronically over a period of ten days.
Proprietà chimiche
Richiesta tecnica su: 3D-XPA52375 TCS-OX2-29
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.
